# Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency

> **NCT03288103** · PHASE1,PHASE2 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 22 (actual)

## Conditions studied

- Short Stature

## Interventions

- **DRUG:** Norditropin

## Key facts

- **NCT ID:** NCT03288103
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-01
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03288103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03288103, "Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03288103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*